Page last updated: 2024-08-24

triazoles and Hematologic Malignancies

triazoles has been researched along with Hematologic Malignancies in 146 studies

Research

Studies (146)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (0.68)	18.2507
2000's	32 (21.92)	29.6817
2010's	92 (63.01)	24.3611
2020's	21 (14.38)	2.80

Authors

Authors	Studies
DiPippo, AJ; Kontoyiannis, DP; McDaneld, PM; Tverdek, FP	1
Honda, S; Itoh, H; Kai, M; Narahara, K; Ogata, M; Okuhiro, K; Shiraiwa, K; Takano, K; Tanaka, R; Tatsuta, R; Yoshida, M; Yoshida, N	1
Carlesse, F; Colombo, AL; Kontoyiannis, DP; Nobrega de Almeida, J; Rossato, L	1
Blijlevens, NMA; Boerrigter, E; Brüggemann, RJ; Lewis, RE; Stanzani, M; Verheggen, R; Verweij, PE	1
Dong, R; Fang, Y; Jin, W; Lin, N; Shan, Q; Shi, C; Wang, L; Xie, Y; Ye, J	1
Chaphekar, N; Cheng, Y; Huang, H; Huang, W; Liu, M; Wu, X; Zheng, Y	1
Alexander, BD; Engemann, A; Johnson, MD; Rizzieri, D; Sarpong, E; Strand, AM; Wong, JR; Wu, Y	1
Bow, EJ; Villalobos, AP	1
Buhl, C; Classen, AY; Cornely, OA; Heinz, WJ; Hoenigl, M; Karthaus, M; Khodamoradi, Y; Klein, M; Koehler, P; Koldehoff, M; Krause, R; Lass-Flörl, C; Liss, B; Maschmeyer, G; Mellinghoff, SC; Penack, O; Ruhnke, M; Schalk, E; Schmidt-Hieber, M; Sprute, R; Stemler, J; Teschner, D; Zapke, SE	1
Cardozo, C; Chumbita, M; García-Vidal, C; Moreno-García, E; Puerta-Alcalde, P	1
Cho, SY; Chung, DR; Huh, K; Jung, CW; Kang, CI; Kim, SH; Lee, SY; Oh, J; Peck, KR	1
Cha, K; Chae, H; Cho, SY; Kim, HJ; Kim, M; Kim, Y; Kim, YJ; Lee, DG; Lee, JJ; Yi, Y	1
Moncada, D; Ramírez, I	1
Calore, E; Cesaro, S; Colombini, A; Comelli, A; De Gregori, S; Decembrino, N; Giardini, I; Goffredo, BM; Molinaro, M; Muggeo, P; Perruccio, K; Scudeller, L; Soncini, E; Zecca, M	1
Chen, J; Dadwal, S; Karras, NA; Pawlowska, A; Rosenthal, J; Ross, JA; Sun, W; Tegtmeier, B; Yamada, C; Zaia, J	1
Baretta, V; Calore, E; Carraro, F; Cesaro, S; Colombini, A; D'Amico, MR; Mauro, M; Muggeo, P; Perruccio, K; Tridello, G; Zama, D	1
Garzon, R; Lapalombella, R; Walker, JS	1
Chen, SC; Cornely, OA; Hoenigl, M; Jenks, JD; Thompson, GR	1
Benkova, K; Hajek, R; Jelinek, T; Mihalyova, J	1
Azmi, AS; Mohammad, RM; Uddin, MH	1
Chen, J; Gao, X; Lai, J; Wang, B; Wu, C; Wu, J; Wu, Z; Yu, B; Zeng, H	1
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE	1
Aitken, SL; Granwehr, B; Heo, ST; Kontoyiannis, DP; Tverdek, FP	1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P	1
Chen, SC; Colombo, AL; de Almeida Júnior, JN; Slavin, MA; Sorrell, TC	1
Benitez, L; Berglund, C; Marini, BL; Miceli, M; Nagel, JL; Perissinotti, AJ; Tang, LA	1
Chauvin, C; Chevallier, P; Dalichampt, M; Deslandes, G; Garnier, A; Gastinne, T; Guillaume, T; Le Bourgeois, A; Le Gouill, S; Moreau, P; Paré, M; Pere, M; Peterlin, P	1
Bae, JY; Bang, SM; Cho, JY; Choe, PG; Hwang, JH; Kim, ES; Kim, HB; Kim, I; Kim, NJ; Koh, Y; Lee, JO; Oh, MD; Park, SI; Park, WB; Song, KH; Song, SH; Suh, HJ; Yoon, SH; Yu, KS	1
Berger, M; Calore, E; Carraro, F; Cesaro, S; Decembrino, N; Molinaro, M; Perruccio, K; Putti, MC; Rossin, S; Tridello, G; Vicenzi, EB	1
Combarel, D; Funck-Brentano, C; Leblond, V; Leclerc, E; Uzunov, M; Zahr, N	1
Blijlevens, NMA; Bouwman, F; Donnelly, JP; Lestrade, PP; Melchers, WJG; Stoop, FJ; van der Velden, WJFM; Verweij, PE	1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L	1
Kontoyiannis, DP; Lewis, RE; Lionakis, MS	1
Ho, CL; Lee, CH; Lin, C; Lin, JC	1
DiPippo, AJ; Kontoyiannis, DP	1
Fontana, L; Hakki, M; Lewis, JS; Noble, BN; Perlin, DS; Strasfeld, L; Zhao, Y	1
Ahmed, G; Ahmed, N; El-Mahallawy, H; Hafez, H; Hassanain, O; Khedr, R; Madney, Y; Taha, H; Youssef, A	1
Chu, HY; Fredricks, DN; Jain, R; Pottinger, P; Xie, H	1
Gao, Y; Ping, B; Wu, B; Yue, C; Zhu, Y	1
De la Serna, J; Fernández-Navarro, JM; Gómez, V; Jarque, I; Jurado, M; López-Jiménez, J; Pascual, A; Romero, M; Serrano, J; Vallejo, C	1
Huitema, AD; Schellens, JH; Schouten-van Meeteren, AY; van Eijkelenburg, NK; van Hasselt, JG	1
Duettmann, W; Fruhwald, S; Hoenigl, M; Krause, R; Prueller, F; Raggam, RB; Seeber, K; Troppan, K; Valentin, T; Wagner, J; Wölfler, A; Zollner-Schwetz, I	1
Ostermann, H; Ostermann, J; Peterson, L; Rieger, CT; Rieger, H	1
Hino, M; Iino, M; Kanamaru, A; Koh, H; Masaoka, T; Ohta, K; Ohyashiki, K; Tamura, K; Tanimoto, M; Urabe, A; Urase, F; Usui, N; Yamaguchi, M; Yamanouchi, J; Yoshida, M	1
Bies, RR; Broxmeyer, HE; Chitnis, SD; Farag, SS; Messina-Graham, S; Strother, RM; Vélez de Mendizábal, N	1
Hoenigl, M; Krause, R; Seeber, K	1
Gamaletsou, MN; Walsh, TJ	1
Caira, M; Pagano, L	1
Chan, RC; Larsen, SR; van Hal, SJ	1
Bradner, JE; Cerulli, R; Frank, DA; Liu, S; Nelson, EA; Qi, J; Stone, RM; Toniolo, PA; Wadleigh, M; Walker, SR; Xiang, M	1
Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG	1
Drew, RH; Johnson, MD; Kung, HC; Perfect, JR; Saha-Chaudhuri, P	1
Bangard, C; Cornely, OA; Shimabukuro-Vornhagen, A; Tran, L; Vehreschild, JJ; Vehreschild, MJ; von Bergwelt-Baildon, M; Wisplinghoff, H	1
Fung, HC; Peksa, GD; Schultz, K	1
Hikota, R; Horiuchi, T; Kato, S; Kimura, F; Kobayashi, A; Kobayashi, S; Maekawa, T; Osawa, Y; Sato, K; Watanabe, J; Yamamura, T	1
Bourdelin, M; Daguindau, E; Deconinck, E; Desbrosses, Y; Dubut, J; Grenouillet, F; Larosa, F; Limat, S; Muret, P	1
Duettmann, W; Hoenigl, M; Huber-Krassnitzer, B; Krause, R; Prattes, J; Prueller, F; Raggam, RB; Seeber, K; Theiler, G; Wagner, J; Wölfler, A; Zollner-Schwetz, I	1
Angelova, O; Auberger, J; Ditlbacher, A; Lackner, M; Lass-Flörl, C; Nachbaur, D; Orth-Höller, D	1
Chen, J; Hu, J; Huang, H; Huang, X; Jin, J; Li, J; Li, Y; Liang, Y; Ma, J; Sun, Y; Wang, C; Wang, J; Wu, D; Xiao, Y; Yu, K	1
Chen, SC; Gilroy, NM; Morrissey, CO; Slavin, MA; Szer, J; Tam, CS; Thursky, KA; van Hal, SJ; Worth, LJ	1
Cassumbhoy, M; Chau, MM; Cooper, CM; Kong, DC; Marriott, DJ; Roberts, JA; Trubiano, JA; Urbancic, K; van Hal, SJ; Wilkes, J; Worth, LJ	1
Han, M; Huang, H; Huang, X; Ji, Y; Meng, F; Ren, H; Shen, Z; Sun, Y; Wang, C; Wu, D; Yu, L; Zhang, X	1
Caddell, R; Craig, M; Cumpston, A; Hamadani, M; Kanate, AS; Lu, X; Shillingburg, A; Wen, S	1
Couriel, DR; Kauffman, CA; Miceli, MH; Perissinotti, AJ	1
Arilla, MJ; Boluda, B; Calvillo, P; Cano, I; Carpio, N; Jarque, I; Lancharro, A; López-Chuliá, F; Lorenzo, I; Martínez, J; Martínez-Cuadrón, D; Montesinos, P; Navarro, I; Pemán, J; Rodríguez-Veiga, R; Salavert, M; Sanz, GF; Sanz, J; Sanz, MA	1
Cha, K; Chae, H; Cho, SY; Kim, HJ; Kim, M; Kim, Y; Kim, YJ; Lee, DG; Lee, S; Yu, H	1
Blanco, JR; Ochoa-Callejero, L	1
Annaert, P; Augustijns, P; Bica, AM; Colita, A; Mols, R; Peersman, N; Spriet, I; Vanstraelen, K; Vermeersch, P	1
Candoni, A; Chandrasekar, P; Connelly, N; Cornely, OA; Duarte, RF; Haider, S; Helfgott, D; Jiménez, JL; Kartsonis, N; Langston, A; Laverdiere, M; Raad, I; Van Iersel, M; Waskin, H	1
Ceesay, MM; Couchman, L; Flanagan, RJ; Pagliuca, A; Smith, M; Wade, J	1
Bang, SM; Cho, JY; Choe, PG; Kim, EJ; Kim, ES; Kim, HB; Kim, I; Kim, NJ; Koh, Y; Lee, JO; Oh, MD; Park, SI; Park, WB; Song, KH; Song, SH; Yoon, S; Yoon, SH; Yu, KS	1
Duettmann, W; Hoenigl, M; Prattes, J	1
Ananda-Rajah, MR; Bajel, A; Chen, SC; Grigg, A; Haywood, P; Jeong, W; Kong, DC; Lindsay, J; Peleg, AY; Ritchie, D; Seymour, JF; Shanmuganathan, N; Slavin, MA; Urbancic, K	1
Bubalo, JS; Lewis, JS; Pham, AN	1
Arnan, M; Ayats, J; Cuenca-Estrella, M; Duarte, RF; Patiño, B; Sánchez-Ortega, I; Sureda, A	1
Gao, P; Sun, L	1
Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Lang, P; Müller, I; Queudeville, M; Schlegel, P	1
Fujimoto, Y; Ikawa, K; Kanbayashi, Y; Nomura, K; Taniwaki, M	1
Imataki, O; Ishida, T; Kitanaka, A; Kubota, Y; Ohnishi, H; Tanaka, T	1
Caira, M; Fianchi, L; Pagano, L	1
Nawrot, U; Nowicka, J; Wlodarczyk, K	1
Caira, M; Candoni, A; Costa, F; Fanin, R; Fianchi, L; Pagano, L; Posteraro, B; Sanguinetti, M; Simeone, E; Valentini, CG; Voso, MT	1
Mehta, J; Pennick, G; Pi, J; Scheetz, MH; Trifilio, SM; Yarnold, PR	1
Hangaishi, A; Imai, Y; Kumano, K; Kurokawa, M; Nannya, Y; Takahashi, T; Ueda, K	1
Maschmeyer, G	1
Caira, M; Fianchi, L; Pagano, L; Valentini, CG	1
Akin, M; Ay, Y; Balkan, C; Karapinar, B; Kavakli, K; Yilmaz, D	1
Bartoni, K; Schiller, GJ; Territo, MC; Winston, DJ	1
Bertz, H; Engelhardt, M; Hieke, S; Jung, M; König, A; Kümmerer, K; Neubauer, WC	1
Berrak, SG; Cakir, E; Cakir, FB; Canpolat, C; Dagli, E; Karakoc, F; Uyan, ZS	1
Lagrou, K; Maertens, J; Meersseman, W; Saegeman, V; Spriet, I; Verbeken, E	1
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR	1
Alanio, A; Botterel, F; Bretagne, S; Cordonnier, C; Costa, JM; Farrugia, C; Foulet, F; Hicheri, Y; Liance, M; Sitterlé, E	1
Chang, FY; Ho, SJ; Lin, JC; Shang, ST; Wang, NC; Yang, YS	1
Aiba, K; Dobashi, N; Kasama, K; Katsube, A; Machishima, T; Minami, J; Nishiwaki, K; Ogasawara, Y; Saito, T; Shimada, T; Sugiyama, K; Takahara, S; Takei, Y; Usui, N; Yahagi, Y; Yamaguchi, Y; Yano, S; Yokoyama, H	1
Jarque, I; Salavert, M	1
Ceballos, P; Cociglio, M; Eiden, C; Eymard-Duvernay, S; Fegueux, N; Hillaire-Buys, D; Le Falher, G; Meniane, JC; Peyrière, H; Reynes, J	1
Delaunay, J; Fraissinet, F; Gastinne, T; Gibas, CF; Le Pape, P; Miegeville, M; Morio, F; Sigler, L	1
Direkze, S; Gant, V; Kibbler, C; Mansour, M; Peggs, KS; Rodriguez-Justo, M	1
Choi, JH; Choi, SM; Han, S; Kim, SH; Kwon, EY; Kwon, JC; Lee, DG; Park, C; Park, SH; Yim, DS; Yoo, JH	1
Caira, M; Leone, G; Pagano, L; Trecarichi, EM; Tumbarello, M	1
Feng, AM; Wei, JY; Yu, WJ	1
Shen, YF; Sun, HL; Zhou, X	1
Cook, G; Cordonnier, C; Hicheri, Y	1
Carreras, E; Casado, MA; de la Cámara, R; Grau, S; Jarque, I; Sabater, FJ; Sanz, MA	1
Hoenigl, M; Krause, R; Raggam, RB; Salzer, HJ; Seeber, K; Sill, H; Strohmeier, AT; Valentin, A; Valentin, T; Wölfler, A; Zollner-Schwetz, I	1
Antin, JH; Armand, P; Baden, LR; Hammond, SP; Koo, S; Kubiak, DW; Marty, FM	1
Best, L; Champlin, RE; Georgiadou, SP; Kontoyiannis, DP; Lewis, RE; Torres, HA	1
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH	1
Bailey, S; Emerson, SG; Frey, NV; Goldstein, SC; Heitjan, DF; Hexner, EO; Hoxie, JA; Loren, AW; Luger, SM; Mick, R; Nasta, SD; Porter, DL; Reshef, R; Smith, J; Stadtmauer, EA; Vonderheide, RH	1
Fasler, D; Gerber, B; Guggenberger, R; Manz, MG; Nair, G; Schanz, U; Stussi, G	1
Huang, XE; Shen, ZS; Su, AL; Xu, YL; Zhang, XQ; Zhang, XZ	1
Aversa, F; Busca, A; Candoni, A; Cesaro, S; Girmenia, C; Luppi, M; Nosari, AM; Pagano, L; Rossi, G; Venditti, A	1
Abu El-Naaj, I; Leiser, Y; Peled, M; Wolff, A	1
Bryant, AM; Craig, M; Cumpston, A; Hamadani, M; Ross, AL; Slain, D	1
Maekawa, T; Yoshioka, S	1
Estes, LL; Wilson, JW; Zeuli, JD	1
Belitsky, G; Budunova, I; Gordon, LI; Kirsanov, K; Lesovaya, E; Popa, A; Rosen, ST; Yakubovskaya, M; Yemelyanov, A	1
Abonour, R; Broxmeyer, HE; Cornetta, K; Farag, SS; Jones, DR; Messina-Graham, S; Robertson, MJ; Schwartz, J; Secrest, A; Srivastava, S; Strother, RM; Wood, L	1
Barberán, J; Carreras, E; Jarque, I; Mensa, J; Serrano, D; Vázquez, L	1
Dadwal, SS; Davies-Vorbrodt, S; Ito, JI; Kriengkauykiat, J; Tegtmeier, BR	1
Cornely, OA; Karthaus, M; Ullmann, AJ	1
Alaggio, R; Cecchetto, G; Cesaro, S; Cusinato, R; Pillon, M; Rigobello, L; Strugo, L; Zanesco, L	1
Baden, LR; DelVecchio, A; Doran, M; Fishman, JA; Katz, JT; Koziol, C; Rubin, RH	1
Candoni, A; Corvatta, L; D'Antonio, D; Del Favero, A; Fianchi, L; Girmenia, C; Martino, P; Nosari, A; Offidani, M; Pagano, L; Picardi, M	1
D'Antonio, D; Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I	1
Mehta, J; Ortiz, R; Pennick, G; Pi, J; Stosor, V; Trifilio, S; Verma, A; Zembower, T	1
Björkholm, M; Cherif, H; Chryssanthou, E; Kalin, M; Petrini, B	1
Böhme, A; Haas, A; Maschmeyer, G	1
Bonatti, H; Dierich, MP; Freund, M; Gastl, G; Griff, K; Kropshofer, G; Lass-Flörl, C; Mayr, A; Nachbaur, D; Petzer, A	1
Bethge, WA; Einsele, H; Hebart, H; Horger, M; Kanz, L; Kröber, SM; Schmalzing, M; Schumacher, U; Stuhler, G	1
Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T	1
Abuhammour, W; Hasan, RA	1
Björkholm, M; Cherif, H; Kalin, M	1
Klastersky, J; Paesmans, M	1
Bennett, CL; Blum, W; Chamilos, G; Evens, A; Kennedy, L; Kontoyiannis, DP; McKoy, JM; Mehta, J; Mullane, K; Palella, F; Parada, J; Scheetz, MH; Tallman, MS; Trifilio, SM; Yarnold, PR	1
Evens, A; Frankfurt, O; Golf, M; Gordon, L; Kaniecki, K; Mehta, J; Pennick, G; Pi, J; Singhal, S; Tallman, M; Trifilio, S; Williams, S; Winter, J; Zook, J	1
Fung, HB; Schiller, DS	1
Afif, C; Boktour, M; Hachem, RY; Hanna, HA; Jiang, Y; Kontoyiannis, DP; Raad, II; Torres, HA	1
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Pizzarelli, G; Pozzi, E	1
Arenz, D; Böhme, A; Cornely, OA; Kiehl, MG; Kochanek, M; Pankraz, K; Reichert, D; Ullmann, AJ; Vehreschild, JJ	1
Alanio, A; Baruchel, A; Brethon, B; de Kerviler, E; Feuilhade de Chauvin, M; Lacroix, C; Leblanc, T; Menotti, J	1
Audouin, AF; Breton, P; Germaud, P; Harousseau, JL; Milpied, N; Morin, O	1
Cassone, A; Girmenia, C; Martino, P; Monaco, M; Mondello, F; Santilli, S; Tuccinardi, C	1
Blumer, JL; Lazarus, HM; Romero, A; Schlamm, H; Yanovich, S	1
Driscoll, T; Dupont, B; Ghahramani, P; Groll, AH; Hodges, M; Lutsar, I; Perfect, JR; Roden, M; Walsh, TJ	1

Reviews

32 review(s) available for triazoles and Hematologic Malignancies

Article	Year
How different is invasive fusariosis in pediatric patients than in adults? A systematic review. Current opinion in infectious diseases, 2021, 12-01, Volume: 34, Issue:6 Topics: Adult; Antifungal Agents; Child; Fusariosis; Hematologic Neoplasms; Humans; Triazoles; Voriconazole	2021
Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs. The Lancet. Haematology, 2022, Volume: 9, Issue:1 Topics: Aged; Antifungal Agents; Drug Interactions; Hematologic Neoplasms; Humans; Pharmaceutical Preparations; Triazoles	2022
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). The Journal of antimicrobial chemotherapy, 2023, 08-02, Volume: 78, Issue:8 Topics: Antifungal Agents; Communicable Diseases; Cytochrome P-450 CYP3A; Hematologic Neoplasms; Hematology; Humans; Invasive Fungal Infections; Medical Oncology; Triazoles	2023
Prophylaxis of mould infections. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32 Suppl 2 Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Fungal Infections; Mycoses; Triazoles	2019
Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp. Mycopathologia, 2020, Volume: 185, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Central Venous Catheters; Echinocandins; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged; Mortality; Neutropenia; Triazoles; Trichosporon; Trichosporonosis; Voriconazole	2020
A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation. Antimicrobial agents and chemotherapy, 2020, 02-21, Volume: 64, Issue:3 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Administration Schedule; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Mucor; Nitriles; Penicillium; Pyridines; Retrospective Studies; Transplantation, Homologous; Triazoles	2020
Selinexor for advanced hematologic malignancies. Leukemia & lymphoma, 2020, Volume: 61, Issue:10 Topics: Cell Line, Tumor; Hematologic Neoplasms; Humans; Hydrazines; Triazoles	2020
Breakthrough invasive fungal infections: Who is at risk? Mycoses, 2020, Volume: 63, Issue:10 Topics: Adrenal Cortex Hormones; Antifungal Agents; Aspergillus; Candida; Central Venous Catheters; Echinocandins; Fluconazole; Fusarium; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Mucorales; Mycoses; Neutropenia; Opportunistic Infections; Organ Transplantation; Penicillium; Risk Factors; Triazoles	2020
Selinexor, selective inhibitor of nuclear export: Unselective bullet for blood cancers. Blood reviews, 2021, Volume: 46 Topics: Active Transport, Cell Nucleus; Antineoplastic Agents; Disease Management; Exportin 1 Protein; Hematologic Neoplasms; Humans; Hydrazines; Karyopherins; Molecular Targeted Therapy; Prognosis; Receptors, Cytoplasmic and Nuclear; Treatment Outcome; Triazoles	2021
The nuclear export protein XPO1 - from biology to targeted therapy. Nature reviews. Clinical oncology, 2021, Volume: 18, Issue:3 Topics: Antineoplastic Agents; Cell Line, Tumor; Dexamethasone; Drug Resistance, Neoplasm; Exportin 1 Protein; Hematologic Neoplasms; Humans; Hydrazines; Karyopherins; Lymphoma, Large B-Cell, Diffuse; Molecular Targeted Therapy; Receptors, Cytoplasmic and Nuclear; Triazoles	2021
Network meta-analysis of triazole, polyene, and echinocandin antifungal agents in invasive fungal infection prophylaxis in patients with hematological malignancies. BMC cancer, 2021, Apr-14, Volume: 21, Issue:1 Topics: Antifungal Agents; Echinocandins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Network Meta-Analysis; Polyenes; Pre-Exposure Prophylaxis; Publication Bias; Treatment Outcome; Triazoles	2021
Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer. The Lancet. Infectious diseases, 2017, Volume: 17, Issue:11 Topics: Antifungal Agents; Biomarkers; Candida; Critical Illness; Decision Support Techniques; Diagnostic Tests, Routine; Echinocandins; Fungi; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Positron-Emission Tomography; Risk Assessment; Triazoles	2017
Primary Fungal Prophylaxis in Hematological Malignancy: a Network Meta-Analysis of Randomized Controlled Trials. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8 Topics: Antifungal Agents; Aspergillosis; Fever; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Invasive Fungal Infections; Network Meta-Analysis; Neutropenia; Opportunistic Infections; Randomized Controlled Trials as Topic; Triazoles	2018
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis. Annals of hematology, 2013, Volume: 92, Issue:6 Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Multicenter Studies as Topic; Mycoses; Neutropenia; Odds Ratio; Patient Dropouts; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Treatment Outcome; Triazoles	2013
Treatment of fungal disease in the setting of neutropenia. Hematology. American Society of Hematology. Education Program, 2013, Volume: 2013 Topics: Anemia, Aplastic; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fusariosis; Fusarium; Hematologic Neoplasms; Humans; Myelodysplastic Syndromes; Neutropenia; Pyrimidines; Scedosporium; Triazoles; Voriconazole	2013
The role of primary antifungal prophylaxis in patients with haematological malignancies. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20 Suppl 6 Topics: Administration, Intravenous; Antibiotic Prophylaxis; Antifungal Agents; Hematologic Neoplasms; Humans; Meta-Analysis as Topic; Mycoses; Practice Guidelines as Topic; Triazoles	2014
Survey of antifungal prophylaxis and fungal diagnostic tests employed in malignant haematology and haemopoietic stem cell transplantation (HSCT) in Australia and New Zealand. Internal medicine journal, 2014, Volume: 44, Issue:12b Topics: Antifungal Agents; Aspergillosis; Australia; Chemoprevention; Consensus Development Conferences as Topic; Data Collection; Diagnostic Tests, Routine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; New Zealand; Opportunistic Infections; Practice Guidelines as Topic; Pre-Exposure Prophylaxis; Triazoles	2014
Consensus guidelines for optimising antifungal drug delivery and monitoring to avoid toxicity and improve outcomes in patients with haematological malignancy, 2014. Internal medicine journal, 2014, Volume: 44, Issue:12b Topics: Antifungal Agents; Consensus; Drug Administration Schedule; Drug Delivery Systems; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Hematologic Neoplasms; Humans; Molecular Sequence Data; Mycoses; Opportunistic Infections; Practice Guidelines as Topic; Rehydration Solutions; Triazoles; Voriconazole	2014
Off-label use of maraviroc in clinical practice. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:1 Topics: Animals; Arthritis, Rheumatoid; CCR5 Receptor Antagonists; Clinical Trials as Topic; Cyclohexanes; Graft vs Host Disease; Hematologic Neoplasms; HIV Fusion Inhibitors; HIV Infections; HIV-1; Humans; Maraviroc; Mice; Off-Label Use; Sarcoidosis; Triazoles	2016
The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Prevention of mould infections. The Journal of antimicrobial chemotherapy, 2009, Volume: 63 Suppl 1 Topics: Antifungal Agents; Chemoprevention; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Mycoses; Neutropenia; Patient Isolation; Pyrimidines; Triazoles; Voriconazole	2009
ZYGOMYCOSIS: current approaches to management of patients with haematological malignancies. British journal of haematology, 2009, Volume: 146, Issue:6 Topics: Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Granulocytes; Hematologic Neoplasms; Humans; Hyperbaric Oxygenation; Iron Chelating Agents; Neutrophils; Risk Factors; Triazoles; Zygomycosis	2009
The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2010, Volume: 43, Issue:3 Topics: Aged; Antifungal Agents; Diabetes Mellitus, Type 2; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Opportunistic Infections; Pyrimidines; Risk Factors; Saccharomycetales; Treatment Outcome; Triazoles; Voriconazole	2010
[Is micafungin useful in the prophylaxis of invasive fungal disease in hematological patients?]. Enfermedades infecciosas y microbiologia clinica, 2011, Volume: 29 Suppl 2 Topics: Adult; Ambulatory Care; Antifungal Agents; Chemical and Drug Induced Liver Injury; Child; Clinical Trials as Topic; Dose-Response Relationship, Drug; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Kidney Diseases; Lipopeptides; Male; Meta-Analysis as Topic; Micafungin; Mycoses; Postoperative Complications; Practice Guidelines as Topic; Triazoles	2011
Uncommon yeast infections in hematological patients: from diagnosis to treatment. Expert review of anti-infective therapy, 2011, Volume: 9, Issue:11 Topics: Antifungal Agents; Blastomyces; Cryptococcus; Echinocandins; Hematologic Neoplasms; Humans; Mycological Typing Techniques; Mycoses; Survival Rate; Triazoles; Trichosporon	2011
Antifungal prophylaxis in haematology patients: the role of voriconazole. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18 Suppl 2 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Clinical Trials as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles; Voriconazole	2012
Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Pharmacotherapy, 2013, Volume: 33, Issue:1 Topics: Body Mass Index; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Middle Aged; Obesity; Overweight; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2013
Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies. Blood, 2003, May-01, Volume: 101, Issue:9 Topics: Adrenal Cortex Hormones; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Clinical Trials as Topic; Disease Susceptibility; Drug Carriers; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Liposomes; Mycoses; Neutropenia; Recurrence; Risk Factors; Triazoles	2003
Mucormycosis in hematologic patients. Haematologica, 2004, Volume: 89, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Encephalitis; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Italy; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Retrospective Studies; Risk Factors; Sinusitis; Treatment Outcome; Triazoles	2004
[Update on therapy of invasive mycoses in hematology and oncology]. Deutsche medizinische Wochenschrift (1946), 2005, Jun-03, Volume: 130, Issue:22 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Caspofungin; Deoxycholic Acid; Drug Combinations; Echinocandins; Hematologic Neoplasms; Humans; Itraconazole; Lipopeptides; Liposomes; Mycoses; Organ Transplantation; Peptides, Cyclic; Pyrimidines; Risk Factors; Stem Cell Transplantation; Triazoles; Voriconazole; Zygomycosis	2005
Invasive aspergillosis in children with hematologic malignancies. Paediatric drugs, 2006, Volume: 8, Issue:1 Topics: Adolescent; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Drug Therapy, Combination; Hematologic Neoplasms; Humans; Triazoles	2006
Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2007, Volume: 15, Issue:2 Topics: Antifungal Agents; Antineoplastic Agents; Aspergillosis; Fever; Hematologic Neoplasms; Humans; Neutropenia; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2007
Posaconazole: an extended-spectrum triazole antifungal agent. Clinical therapeutics, 2007, Volume: 29, Issue:9 Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Candidiasis; Drug Resistance, Fungal; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Tissue Distribution; Triazoles	2007

Trials

17 trial(s) available for triazoles and Hematologic Malignancies

Article	Year
High-throughput simultaneousquantification offive azole anti-fungal agents and one active metabolite in human plasma using ultra-high-performance liquid chromatography coupled to tandem mass spectrometry. Clinical biochemistry, 2022, Volume: 99 Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Tandem Mass Spectrometry; Triazoles	2022
Empirical voriconazole therapy for febrile neutropenic patients with hematological disorders: a prospective multicenter trial in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2013, Volume: 19, Issue:6 Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Antigens, Fungal; Febrile Neutropenia; Female; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Pyrimidines; Triazoles; Voriconazole; Young Adult	2013
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis. PloS one, 2014, Volume: 9, Issue:2 Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole	2014
Clinical effectiveness of posaconazole versus fluconazole as antifungal prophylaxis in hematology-oncology patients: a retrospective cohort study. Cancer medicine, 2014, Volume: 3, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Female; Fluconazole; Hematologic Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mycoses; Retrospective Studies; Treatment Outcome; Triazoles; United States	2014
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: a 6-yr analysis from the cologne cohort for neutropenic patients. European journal of haematology, 2014, Volume: 93, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Drug Therapy, Combination; Echinocandins; Female; Follow-Up Studies; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Mycoses; Neutropenia; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Triazoles	2014
Determination of posaconazole concentration with LC-MS/MS in adult patients with hematologic malignancy. Clinica chimica acta; international journal of clinical chemistry, 2015, Oct-23, Volume: 450 Topics: Adolescent; Adult; Aged; Antifungal Agents; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Tandem Mass Spectrometry; Triazoles; Young Adult	2015
Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:3 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Female; Fungemia; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Plasma; Survival Analysis; Tablets; Triazoles; Young Adult	2016
Posaconazole Tablet Formulation at 400 Milligrams Daily Achieves Desired Minimum Serum Concentrations in Adult Patients with a Hematologic Malignancy or Stem Cell Transplant. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:11 Topics: Adult; Aged; Antifungal Agents; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Treatment Outcome; Triazoles	2016
Efficacy, safety and feasibility of antifungal prophylaxis with posaconazole tablet in paediatric patients after haematopoietic stem cell transplantation. Journal of cancer research and clinical oncology, 2017, Volume: 143, Issue:7 Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mycoses; Tablets; Triazoles	2017
Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:4 Topics: Adolescent; Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Triazoles; Young Adult	2011
Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2011, Volume: 15, Issue:11 Topics: Adult; Alleles; Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Aspergillosis; Aspergillus; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Hematologic Neoplasms; Humans; Immunocompromised Host; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyrimidines; Republic of Korea; Risk Factors; Triazoles; Voriconazole; Young Adult	2011
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. The New England journal of medicine, 2012, Jul-12, Volume: 367, Issue:2 Topics: Adult; Aged; CCR5 Receptor Antagonists; Chemokine CCL3; Chemokine CCL5; Chemotaxis, Leukocyte; Cyclohexanes; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Male; Maraviroc; Middle Aged; T-Lymphocytes; Transplantation, Homologous; Triazoles; Young Adult	2012
Phase II study on voriconazole for treatment of Chinese patients with malignant hematological disorders and invasive aspergillosis. Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:5 Topics: Administration, Oral; Antifungal Agents; Aspergillosis; Female; Follow-Up Studies; Hematologic Neoplasms; Humans; Male; Middle Aged; Prognosis; Pyrimidines; Triazoles; Voriconazole	2012
In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies. Stem cells and development, 2013, Apr-01, Volume: 22, Issue:7 Topics: Adult; Cord Blood Stem Cell Transplantation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Female; Fetal Blood; Hematologic Neoplasms; Humans; Male; Middle Aged; Pilot Projects; Pyrazines; Sitagliptin Phosphate; Transplantation Conditioning; Triazoles; Young Adult	2013
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia, 2008, Volume: 22, Issue:3 Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Caspofungin; Combined Modality Therapy; Drug Combinations; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Itraconazole; Lipopeptides; Male; Middle Aged; Neutropenia; Phosphatidylcholines; Phosphatidylglycerols; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2008
Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study. Journal of clinical pharmacology, 2002, Volume: 42, Issue:4 Topics: Administration, Oral; Adult; Antifungal Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Graft Rejection; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Risk Factors; Triazoles; Voriconazole	2002
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. The Pediatric infectious disease journal, 2002, Volume: 21, Issue:3 Topics: Adolescent; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Administration Schedule; Female; Granulomatous Disease, Chronic; Hematologic Neoplasms; Humans; Infant; Male; Mycoses; Pyrimidines; Treatment Failure; Triazoles; Voriconazole	2002

Other Studies

97 other study(ies) available for triazoles and Hematologic Malignancies

Article	Year
Effect of High-Dose Posaconazole on Serum Levels in Adult Patients with Hematologic Malignancy. Antimicrobial agents and chemotherapy, 2021, 11-17, Volume: 65, Issue:12 Topics: Administration, Oral; Adult; Antifungal Agents; Hematologic Neoplasms; Humans; Retrospective Studies; Triazoles	2021
Cost-Effectiveness of Posaconazole vs. First-Generation Triazoles for the Prevention of Invasive Fungal Infections Among High-Risk Patients With Hematological Malignancies in China. Frontiers in public health, 2022, Volume: 10 Topics: Antifungal Agents; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Mycoses; Tablets; Triazoles	2022
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy. European journal of clinical pharmacology, 2022, Volume: 78, Issue:9 Topics: Adult; Antifungal Agents; Bayes Theorem; China; Hematologic Neoplasms; Humans; Models, Biological; Triazoles; Voriconazole	2022
Real-world effectiveness of antifungal prophylaxis with posaconazole as the primary agent in patients with haematological malignancies. Mycoses, 2022, Volume: 65, Issue:11 Topics: Adult; Antifungal Agents; Hematologic Neoplasms; Humans; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles	2022
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice? Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:2 Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Nitriles; Triazoles	2023
Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level. Mycoses, 2020, Volume: 63, Issue:1 Topics: Administration, Oral; Adult; Antifungal Agents; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Hypoalbuminemia; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Suspensions; Tablets; Treatment Outcome; Triazoles	2020
Evaluation of posaconazole plasma concentrations achieved with the delayed-release tablets in Korean high-risk patients with haematologic malignancy. Mycoses, 2020, Volume: 63, Issue:2 Topics: Adult; Antifungal Agents; Biological Availability; Chromatography, Liquid; Cohort Studies; Delayed-Action Preparations; Female; Glucuronosyltransferase; Hematologic Neoplasms; Heterozygote; Humans; Liver; Male; Middle Aged; Multivariate Analysis; Pharmacogenetics; Polymorphism, Genetic; Regression Analysis; Retrospective Studies; Tablets; Tandem Mass Spectrometry; Triazoles	2020
Safety of Isavuconazonium Sulfate in Pediatrics Patients With Hematologic Malignancies and Hematopoietic Cell Transplantation With Invasive Fungal Infections: A Real World Experience. Journal of pediatric hematology/oncology, 2020, Volume: 42, Issue:4 Topics: Adolescent; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Nitriles; Pyridines; Retrospective Studies; Triazoles	2020
Posaconazole delayed-release tablets in paediatric haematology-oncology patients. Mycoses, 2020, Volume: 63, Issue:6 Topics: Administration, Oral; Adolescent; Antifungal Agents; Child; Child, Preschool; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Retrospective Studies; Tablets; Triazoles	2020
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, Jul-15, Volume: 65, Issue:2 Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Real-Life Assessment of the Safety and Effectiveness of the New Tablet and Intravenous Formulations of Posaconazole in the Prophylaxis of Invasive Fungal Infections via Analysis of 343 Courses. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Algorithms; Antifungal Agents; Cohort Studies; Drug Compounding; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Pre-Exposure Prophylaxis; Retrospective Studies; Tablets; Tertiary Care Centers; Treatment Outcome; Triazoles	2017
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. International journal of antimicrobial agents, 2017, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Risk factors for subtherapeutic levels of posaconazole tablet. The Journal of antimicrobial chemotherapy, 2017, 10-01, Volume: 72, Issue:10 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Pre-Exposure Prophylaxis; Retrospective Studies; Risk Factors; Tablets; Triazoles; Young Adult	2017
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES Study. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:2 Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Female; Fungi; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Stomach; Tablets; Triazoles; Young Adult	2018
Early Therapeutic Drug Monitoring of Posaconazole Oral Suspension in Patients With Hematologic Malignancies. Therapeutic drug monitoring, 2018, Volume: 40, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Case-Control Studies; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Prospective Studies; Suspensions; Time Factors; Triazoles; Young Adult	2018
Posaconazole oral dose and plasma levels in pediatric hematology-oncology patients. European journal of haematology, 2018, Volume: 100, Issue:3 Topics: Administration, Oral; Adolescent; Anemia, Aplastic; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Administration Schedule; Drug Dosage Calculations; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunologic Deficiency Syndromes; Infant; Lymphohistiocytosis, Hemophagocytic; Male; Mycoses; Remission Induction; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Triazoles	2018
Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies. Scientific reports, 2018, 01-26, Volume: 8, Issue:1 Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Plasma; Suspensions; Tablets; Treatment Outcome; Triazoles	2018
Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study. The Journal of antimicrobial chemotherapy, 2018, 05-01, Volume: 73, Issue:5 Topics: Antifungal Agents; Aspergillus fumigatus; Drug Resistance, Fungal; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Prevalence; Retrospective Studies; Triazoles	2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2018
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 10-30, Volume: 67, Issue:10 Topics: Adult; Antifungal Agents; Chemoprevention; Disease Management; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Prospective Studies; Risk Factors; Transplantation, Homologous; Triazoles	2018
Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-15, Volume: 69, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Liver; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Skin; Triazoles; Young Adult	2019
Isavuconazole Prophylaxis in Patients With Hematologic Malignancies and Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 02-14, Volume: 70, Issue:5 Topics: Adult; Antifungal Agents; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Nitriles; Pyridines; Retrospective Studies; Transplant Recipients; Triazoles	2020
Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt. Mycoses, 2019, Volume: 62, Issue:11 Topics: Adolescent; Amphotericin B; Antifungal Agents; Cancer Care Facilities; Child; Child, Preschool; Egypt; Female; Hematologic Neoplasms; Hospitals, Pediatric; Humans; Immunocompromised Host; Male; Mucormycosis; Neoplasms; Opportunistic Infections; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles	2019
Voriconazole therapeutic drug monitoring: retrospective cohort study of the relationship to clinical outcomes and adverse events. BMC infectious diseases, 2013, Feb-26, Volume: 13 Topics: Adult; Antifungal Agents; Brain Diseases, Metabolic; Candidiasis; Drug Administration Schedule; Drug Monitoring; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Liver; Male; Middle Aged; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2013
Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Candidiasis, Invasive; Child; Child, Preschool; Combined Modality Therapy; Cross Infection; Drug Evaluation; Female; Fungemia; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Myelodysplastic Syndromes; Neutropenia; Postoperative Complications; Retrospective Studies; Risk; Transplantation, Homologous; Treatment Outcome; Triazoles; Young Adult	2013
Severe skin toxicity in pediatric oncology patients treated with voriconazole and concomitant methotrexate. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6 Topics: Adolescent; Antibiotic Prophylaxis; Antifungal Agents; Antimetabolites, Antineoplastic; Aspergillosis; Cheilitis; Child; Child, Preschool; Dermatitis, Photoallergic; Drug Therapy, Combination; Female; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Leukemia, Megakaryoblastic, Acute; Male; Methotrexate; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole	2013
Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:7 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Body Mass Index; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Intensive Care Units; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
Posaconazole prophylaxis--impact on incidence of invasive fungal disease and antifungal treatment in haematological patients. Mycoses, 2013, Volume: 56, Issue:6 Topics: Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Incidence; Male; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Young Adult	2013
Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation. Clinical pharmacokinetics, 2014, Volume: 53, Issue:3 Topics: Area Under Curve; Cord Blood Stem Cell Transplantation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Hematologic Neoplasms; Humans; Population; Pyrazines; Sitagliptin Phosphate; Triazoles	2014
Antifungal prophylaxis following allogeneic haematopoietic stem cell transplantation: what is the role of voriconazole? Infection, 2014, Volume: 42, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Pyrimidines; Triazoles	2014
Is there still a place for itraconazole prophylaxis in high-risk hematology patients? Annals of hematology, 2014, Volume: 93, Issue:9 Topics: Antifungal Agents; Hematologic Neoplasms; Humans; Mycoses; Triazoles	2014
Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. Molecular cancer therapeutics, 2014, Volume: 13, Issue:5 Topics: Azepines; Benzodiazepines; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Hematologic Neoplasms; Humans; Leukemia; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; RNA, Small Interfering; STAT5 Transcription Factor; Transcription Factors; Triazoles	2014
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2015, Volume: 21, Issue:6 Topics: Adult; Aged; Algorithms; Antifungal Agents; Azoles; Drug Dosage Calculations; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Retrospective Studies; Sirolimus; Tacrolimus; Triazoles; Voriconazole; Young Adult	2015
Elevated total iron-binding capacity as a predictor of response to deferasirox therapy in the setting of chronic iron overload. International journal of hematology, 2014, Volume: 100, Issue:3 Topics: Benzoates; Blood Proteins; Deferasirox; Drug Monitoring; Female; Ferritins; Hematologic Neoplasms; Humans; Iron; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Multivariate Analysis; Prognosis; Protein Binding; Retrospective Studies; ROC Curve; Transfusion Reaction; Treatment Outcome; Triazoles	2014
Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice. Medical mycology, 2014, Volume: 52, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Treatment Outcome; Triazoles; Withholding Treatment; Young Adult	2014
Impact of structured personal on-site patient education on low posaconazole plasma concentrations in patients with haematological malignancies. International journal of antimicrobial agents, 2014, Volume: 44, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Austria; Chemoprevention; Cohort Studies; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Medication Adherence; Middle Aged; Mycoses; Patient Education as Topic; Plasma; Triazoles; Young Adult	2014
Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study. European journal of haematology, 2015, Volume: 94, Issue:3 Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Administration Schedule; Echinocandins; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Injections, Intravenous; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Triazoles; Trichosporon; Trichosporonosis	2015
Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2015, Volume: 36, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Child, Preschool; China; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mycoses; Risk Factors; Triazoles	2015
Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2015, Volume: 21, Issue:6 Topics: Adolescent; Adult; Antifungal Agents; China; Chronic Disease; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Mycoses; Myeloablative Agonists; Neutropenia; Prognosis; Prospective Studies; Risk Factors; Siblings; Survival Analysis; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Triazoles; Unrelated Donors	2015
Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Chemistry, Pharmaceutical; Delayed-Action Preparations; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Suspensions; Tablets; Triazoles; Young Adult	2015
Serum posaconazole levels among haematological cancer patients taking extended release tablets is affected by body weight and diarrhoea: single centre retrospective analysis. Mycoses, 2015, Volume: 58, Issue:7 Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Biological Availability; Body Mass Index; Body Weight; Delayed-Action Preparations; Diarrhea; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Tablets; Triazoles; Young Adult	2015
Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis. Bone marrow transplantation, 2015, Volume: 50, Issue:11 Topics: Administration, Oral; Adult; Aged; Allografts; Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Cause of Death; Drug Therapy, Combination; Echinocandins; Female; Fungemia; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Lipopeptides; Male; Medication Adherence; Middle Aged; Mycoses; Neutropenia; Patient Compliance; Premedication; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis; Transplantation Conditioning; Treatment Failure; Triazoles; Young Adult	2015
Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area. The Pediatric infectious disease journal, 2016, Volume: 35, Issue:2 Topics: Administration, Oral; Adolescent; Antifungal Agents; Body Surface Area; Child; Child, Preschool; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Mycoses; Plasma; Prospective Studies; Suspensions; Triazoles	2016
Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome. Medical mycology, 2016, Oct-01, Volume: 54, Issue:7 Topics: Adult; Aged; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Serum; Treatment Outcome; Triazoles; Young Adult	2016
Effectiveness of increasing the frequency of posaconazole syrup administration to achieve optimal plasma concentrations in patients with haematological malignancy. International journal of antimicrobial agents, 2016, Volume: 48, Issue:1 Topics: Administration, Oral; Adult; Antifungal Agents; Chemoprevention; Chromatography, Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Tandem Mass Spectrometry; Triazoles	2016
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:9 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; ROC Curve; Triazoles	2016
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12 Topics: Administration, Intravenous; Adult; Antifungal Agents; Australia; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Plasma; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Triazoles	2016
Serum galactomannan surveillance may be safely withdrawn from antifungal management of hematology patients on effective antimold prophylaxis: a pilot single-center study. Bone marrow transplantation, 2017, Volume: 52, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Fungi; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Mannans; Middle Aged; Mycoses; Prospective Studies; Triazoles	2017
Small molecules remain on target for c-Myc. eLife, 2017, 01-19, Volume: 6 Topics: Animals; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Hematologic Neoplasms; Humans; Mice; Nuclear Proteins; Proto-Oncogene Proteins c-myc; Reproducibility of Results; Transcription Factors; Triazoles; Xenograft Model Antitumor Assays	2017
Pharmacokinetic-pharmacodynamic analysis of voriconazole in Japanese patients with hematological malignancies. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2008, Volume: 27, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hematologic Neoplasms; Humans; Male; Metabolic Clearance Rate; Middle Aged; Monte Carlo Method; Mycoses; Pyrimidines; Tissue Distribution; Triazoles; Voriconazole	2008
Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population. International journal of hematology, 2008, Volume: 88, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Asian People; Female; Hallucinations; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole	2008
Pulmonary aspergillosis in hematologic malignancies: lights and shadows. Haematologica, 2008, Volume: 93, Issue:11 Topics: Antifungal Agents; Aspergillosis; Hematologic Neoplasms; Humans; Lung Diseases; Pyrimidines; Sensitivity and Specificity; Triazoles; Voriconazole	2008
Susceptibility to voriconazole, fluconazole, and ketoconazole of yeast isolated from patients with hematological malignancies. Journal of chemotherapy (Florence, Italy), 2008, Volume: 20, Issue:6 Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Hematologic Neoplasms; Humans; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2008
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies. Mycoses, 2010, Volume: 53, Issue:1 Topics: Aged; Amphotericin B; Antifungal Agents; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Treatment Outcome; Triazoles; Zygomycosis	2010
Serial plasma voriconazole concentrations after allogeneic hematopoietic stem cell transplantation. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5 Topics: Adult; Antifungal Agents; Chemoprevention; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Transplantation, Homologous; Triazoles; Voriconazole	2009
Monitoring trough concentration of voriconazole is important to ensure successful antifungal therapy and to avoid hepatic damage in patients with hematological disorders. International journal of hematology, 2009, Volume: 89, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Dose-Response Relationship, Drug; Drug Monitoring; Hematologic Neoplasms; Humans; Liver Diseases; Male; Middle Aged; Mycoses; Pyrimidines; Triazoles; Voriconazole; Young Adult	2009
A rescue therapy with a combination of caspofungin and liposomal amphotericin B or voriconazole in children with haematological malignancy and refractory invasive fungal infections. Mycoses, 2011, Volume: 54, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Female; Fungi; Hematologic Neoplasms; Humans; Infant; Lipopeptides; Male; Mycoses; Pyrimidines; Salvage Therapy; Treatment Outcome; Triazoles; Voriconazole	2011
Therapeutic drug monitoring of posaconazole in hematology patients: experience with a new high-performance liquid chromatography-based method. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Adult; Aged; Antifungal Agents; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Prospective Studies; Triazoles	2010
Invasive respiratory aspergillosis is a treatable disease with early diagnosis and aggressive therapy. Pediatric hematology and oncology, 2010, Volume: 27, Issue:6 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Early Diagnosis; Echinocandins; Female; Fever; Hematologic Neoplasms; Humans; Lipopeptides; Male; Neutropenia; Prognosis; Pulmonary Aspergillosis; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2010
Increasing incidence of mucormycosis in University Hospital, Belgium. Emerging infectious diseases, 2010, Volume: 16, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Belgium; Child; Female; Hematologic Neoplasms; Hospitals, University; Humans; Incidence; Male; Middle Aged; Mucormycosis; Pyrimidines; Risk Factors; Triazoles; Voriconazole; Young Adult	2010
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2011, Volume: 17, Issue:7 Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole	2011
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies. The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Azoles; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; France; Fungal Proteins; Hematologic Neoplasms; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Pyrimidines; Triazoles; Tubulin; Voriconazole	2011
Rapid progression and unusual premortal diagnosis of mucormycosis in patients with hematologic malignancies: analysis of eight patients. International journal of hematology, 2011, Volume: 93, Issue:3 Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Biopsy; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole	2011
Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Antineoplastic Agents; Chemoprevention; Drug Monitoring; Eating; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Triazoles; Young Adult	2012
Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay. Medical mycology, 2011, Volume: 49, Issue:8 Topics: Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Base Sequence; Cross Reactions; Diagnosis, Differential; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Middle Aged; Molecular Sequence Data; Mycoses; Neutropenia; Pyrimidines; Sensitivity and Specificity; Sordariales; Spores, Fungal; Triazoles; Voriconazole	2011
Candida kefyr fungal enteritis following autologous BMT. Bone marrow transplantation, 2012, Volume: 47, Issue:3 Topics: Bone Marrow Transplantation; Candida; Candidiasis; Endoscopy; Enteritis; Hematologic Neoplasms; Humans; Male; Middle Aged; Tomography, X-Ray Computed; Triazoles; Waldenstrom Macroglobulinemia	2012
[Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
[Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2011, Volume: 32, Issue:8 Topics: Adolescent; Adult; Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2011
Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain. BMC infectious diseases, 2012, Apr-03, Volume: 12 Topics: Antifungal Agents; Chemoprevention; Cost-Benefit Analysis; Hematologic Neoplasms; Humans; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Prospective Studies; Spain; Triazoles	2012
Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies. International journal of antimicrobial agents, 2012, Volume: 39, Issue:6 Topics: Adult; Antifungal Agents; Aspergillosis; Chemoprevention; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Risk Factors; Triazoles; Young Adult	2012
Safety of posaconazole and sirolimus coadministration in allogeneic hematopoietic stem cell transplants. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2012, Volume: 18, Issue:9 Topics: Adult; Antifungal Agents; Drug Administration Schedule; Drug Dosage Calculations; Drug Synergism; Drug Therapy, Combination; Female; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycoses; Sirolimus; Transplantation, Homologous; Triazoles	2012
The impact of prior invasive mold infections in leukemia patients who undergo allo-SCT in the era of triazole-based secondary prophylaxis. Bone marrow transplantation, 2013, Volume: 48, Issue:1 Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Child; Cohort Studies; Drug Therapy, Combination; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Male; Middle Aged; Mycoses; Retrospective Studies; Secondary Prevention; Transplantation, Homologous; Triazoles; Young Adult	2013
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies. Medical mycology, 2013, Volume: 51, Issue:3 Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2013
Reversible skeletal disease and high fluoride serum levels in hematologic patients receiving voriconazole. Blood, 2012, Sep-20, Volume: 120, Issue:12 Topics: Adult; Antifungal Agents; Bone Diseases; Female; Fluorides; Hematologic Neoplasms; Humans; Itraconazole; Middle Aged; Muscle, Skeletal; Periostitis; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous; Triazoles; Voriconazole	2012
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associaz Hematological oncology, 2013, Volume: 31, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Chemotherapy-Induced Febrile Neutropenia; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Fungal; Drug Therapy, Combination; Febrile Neutropenia; Fungi; Hematologic Neoplasms; Humans; Immunocompromised Host; Multicenter Studies as Topic; Mycoses; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Transplantation Conditioning; Triazoles	2013
The surgical management of rhinocerebral mucormycosis. Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery, 2013, Volume: 41, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Brain Diseases; Cause of Death; Combined Modality Therapy; Diagnosis, Differential; Fatal Outcome; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Maxillary Sinusitis; Middle Aged; Mucormycosis; Nose Diseases; Paranasal Sinus Diseases; Pyrimidines; Triazoles; Voriconazole; Young Adult	2013
Evaluation of an alternative posaconazole prophylaxis regimen in haematological malignancy patients receiving concomitant stress ulcer prophylaxis. International journal of antimicrobial agents, 2012, Volume: 40, Issue:6 Topics: Adult; Aged; Antifungal Agents; Chemoprevention; Drug Interactions; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Mycoses; Plasma; Proton Pump Inhibitors; Stress, Physiological; Triazoles; Ulcer	2012
[Transfusion reaction and HLA antibodies]. Nihon rinsho. Japanese journal of clinical medicine, 2012, Volume: 70 Suppl 2 Topics: Acute Lung Injury; Antibody Formation; Benzoates; Blood Transfusion; Deferasirox; Hematologic Neoplasms; Hemochromatosis; HLA Antigens; Humans; Iron Chelating Agents; Isoantibodies; Myelodysplastic Syndromes; Transfusion Reaction; Triazoles	2012
Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Fluconazole; Hematologic Neoplasms; Humans; Hypokalemia; Levofloxacin; Long QT Syndrome; Male; Middle Aged; Mycoses; Ofloxacin; Pyrimidines; Risk Factors; Torsades de Pointes; Triazoles; Ventricular Dysfunction, Left; Voriconazole	2013
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies. Cell cycle (Georgetown, Tex.), 2013, Jan-01, Volume: 12, Issue:1 Topics: Apoptosis; Boronic Acids; Bortezomib; Cell Line, Tumor; Dexamethasone; Dimerization; Drug Synergism; Hematologic Neoplasms; Humans; K562 Cells; Lymphoma; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proteasome Inhibitors; Pyrazines; Receptors, Glucocorticoid; RNA Interference; RNA, Small Interfering; Transcription Factor AP-1; Transcriptional Activation; Triazoles; Tumor Cells, Cultured	2013
Antifungal prophylaxis in the haematological patient: a practical approach. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2012, Volume: 25, Issue:4 Topics: Algorithms; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Biological Availability; Decision Trees; Drug Interactions; Echinocandins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Liver Diseases; Mycoses; Myelodysplastic Syndromes; Postoperative Complications; Practice Guidelines as Topic; Premedication; Triazoles	2012
Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:11 Topics: Adolescent; Amphotericin B; Anemia, Aplastic; Anemia, Refractory; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Hematologic Neoplasms; Humans; Leukemia, Myelomonocytic, Acute; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Time Factors; Treatment Outcome; Triazoles; Voriconazole	2003
Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Transplantation, 2003, Dec-15, Volume: 76, Issue:11 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Middle Aged; Mycoses; Neoplasms; Pyrimidines; Salvage Therapy; Transplantation; Treatment Failure; Triazoles; Voriconazole	2003
In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:11 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Caspofungin; Colony Count, Microbial; Echinocandins; Fluconazole; Hematologic Neoplasms; Humans; Kinetics; Lipopeptides; Microbial Sensitivity Tests; Models, Biological; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole	2004
Voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients. Bone marrow transplantation, 2005, Volume: 35, Issue:5 Topics: Alkaline Phosphatase; Antifungal Agents; Aspartate Aminotransferases; Chromatography, High Pressure Liquid; Drug Monitoring; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Premedication; Pyrimidines; Retrospective Studies; Transplantation, Homologous; Triazoles; Voriconazole	2005
Surveillance of triazole susceptibility of colonizing yeasts in patients with haematological malignancies. Scandinavian journal of infectious diseases, 2004, Volume: 36, Issue:11-12 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Agents; Female; Fungi; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Neutropenia; Triazoles	2004
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. British journal of haematology, 2005, Volume: 131, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Austria; Caspofungin; Drug Resistance, Fungal; Echinocandins; Female; Genes, Fungal; Hematologic Neoplasms; Humans; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Organ Transplantation; Peptides, Cyclic; Prevalence; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole	2005
Mucormycoses in patients with hematologic malignancies: an emerging fungal infection. Haematologica, 2005, Volume: 90 Suppl Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Communicable Diseases, Emerging; Dermatomycoses; Disease Susceptibility; Female; Fluconazole; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Mucormycosis; Neutropenia; Pyrimidines; Sinusitis; Transplantation Conditioning; Triazoles; Viscera; Voriconazole	2005
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. Haematologica, 2006, Volume: 91, Issue:2 Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2006
Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? European journal of haematology, 2006, Volume: 77, Issue:4 Topics: Adult; Aged; Antifungal Agents; Caspofungin; Echinocandins; Female; Hematologic Neoplasms; Humans; Lipopeptides; Male; Middle Aged; Mycoses; Peptides, Cyclic; Prospective Studies; Pyrimidines; Triazoles; Voriconazole	2006
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Bone marrow transplantation, 2007, Volume: 39, Issue:7 Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis	2007
Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer, 2007, Apr-15, Volume: 109, Issue:8 Topics: Antifungal Agents; Graft Rejection; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Mycoses; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole	2007
Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole. Haematologica, 2008, Volume: 93, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Anemia, Aplastic; Aspergillosis; Child; Cohort Studies; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole. International journal of hematology, 2008, Volume: 87, Issue:2 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Mycoses; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole	2008
Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, May-15, Volume: 46, Issue:10 Topics: Adolescent; Antifungal Agents; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Hematologic Neoplasms; Humans; Lipopeptides; Male; Mycoses; Neutropenia; Pneumonia; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Triazoles; Trichoderma; Voriconazole	2008
[Rare pulmonary mycoses in patients with hematologic diseases]. Revue de pneumologie clinique, 1998, Volume: 54, Issue:5 Topics: Acremonium; Adolescent; Adult; Amphotericin B; Antifungal Agents; Antineoplastic Agents; Bone Marrow Transplantation; Female; Hematologic Neoplasms; Humans; Imidazoles; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Middle Aged; Multiple Myeloma; Neutropenia; Penicillium; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria; Pyrimidines; Risk Factors; Triazoles; Voriconazole	1998
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. The Journal of antimicrobial chemotherapy, 2000, Volume: 46, Issue:3 Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole	2000